# US 2019/0167714 A1 · Hydrogel compositions and uses thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0167714 A1
- Document ID: US20190167714A1
- Status: Published application
- Kind: A1
- Application number: 16/203,872
- Filed: 2018-11-29
- Published: 2019-06-06
- Earliest claimed: 2017-12-01
- Assignees: Zoetis Services LLC
- Applicants: Zoetis Services LLC
- Inventors: Christina Lee Brown; ALEXANDRE THERRIEN; NICOLAS COTTENYE; OSCAR SUAREZ
- Web page: https://patentgrep.com/patent/US20190167714A1

## CPC

- A61K 31/722: Chitin, chitosan
- A61K 9/0024: {Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue (compositions for intravenous administration, normal injectable solutions or dispersions for, e.g. subcutaneous administration A61K9/0019; brain implants A61K9/0085; (coated) prostheses, catheters or stents A61L)}
- A61K 9/0041: {Mammary glands, e.g. breasts, udder; Intramammary administration}
- A61K 9/06: Ointments; Bases therefor; {Other semi-solid forms, e.g. creams, sticks, gels (composition of ointments, creams or gels A61K47/00)}
- A61K 47/02: Inorganic compounds
- A61K 47/10: Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A61K 47/12: Carboxylic acids; Salts or anhydrides thereof
- A61K 47/36: Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61L 27/446: {with other specific inorganic fillers other than those covered by A61L27/443 or A61L27/46}
- A61L 27/46: with phosphorus-containing inorganic fillers
- A61L 27/50: Materials characterised by their function or physical properties {, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials}
- A61L 31/127: {containing fillers of phosphorus-containing inorganic materials}
- A61L 31/128: {containing other specific inorganic fillers not covered by A61L31/126 or A61L31/127}
- A61L 31/14: Materials characterised by their function or physical properties {, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials}
- A61L 2400/06: Flowable or injectable implant compositions
- A61P 15/14: for lactation disorders, e.g. galactorrhoea
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present application provides compositions configured to be provided in a flowable, liquid form but that are configured to transition to a solid or semi-solid gel based upon a change in pH. The change in pH can arise from one or more materials utilized in the composition itself or based upon encountering an environment with a significantly different pH. The compositions are particularly suited for use as a teat sealant in non-human mammals, particularly cattle.

## Claims

### Claim 1

A composition comprising:
chitosan;
a biocompatible acid;
a filler,
a fluidizing agent; and
at least 50% by weight of an aqueous medium based upon the total weight of the composition;
wherein the composition is a flowable liquid at a pH of less than 6 less and is a solid or semi-solid gel at a pH of about 6.5 or greater.

### Claim 2 (depends on 1)

The composition of claim 1, wherein the chitosan is present in an amount of about 2% to about 5% by weight based on the total weight of the composition.

### Claim 3 (depends on 1)

The composition of claim 1, wherein the chitosan has a degree of deacetylation of greater than 90%.

### Claim 4 (depends on 1)

The composition of claim 1, wherein the biocompatible acid is present in an amount of about 0.5% to about 5% by weight based on the total weight of the composition.

### Claim 5 (depends on 1)

The composition of claim 1, wherein the biocompatible acid is an organic acid.

### Claim 6 (depends on 5)

The composition of claim 5, wherein the biocompatible acid is acetic acid.

### Claim 7 (depends on 1)

The composition of claim 1, wherein the chitosan and the biocompatible acid are present in a chitosan to acid weight ratio of about 1:1 to about 4:1.

### Claim 8 (depends on 1)

The composition of claim 1, wherein the filler is present in an amount of about 10% to about 40% by weight based on the total weight of the composition.

### Claim 9 (depends on 1)

The composition of claim 1, wherein the filler is selected from the group consisting of calcium phosphate, aluminum oxide, calcium carbonate, silicon dioxide, and combinations thereof.

### Claim 10 (depends on 1)

The composition of claim 1, wherein the fluidizing agent is selected from the group consisting of polyethylene glycol, glycerol, and combinations thereof.

### Claim 11 (depends on 1)

The composition of claim 1, wherein the composition is substantially free of any cellulosic material.

### Claim 12 (depends on 1, 11)

A method of treating a non-human mammal, the method comprising administering a composition according to any of claim 1 through claim 11 to a teat, teat canal, or teat cistern of the non-human mammal.
